Back to search results

Counseling for Breast Cancer-Related Distress

This study is looking at whether a single, one-hour counseling session can help reduce feelings of depression, anxiety, and general distress in women with breast cancer. This session is called the "Single Counseling Session for Cancer" and focuses on problem-solving to help you manage challenges related to your cancer diagnosis and treatment. You would also receive an American Cancer Society booklet called "After Diagnosis: A Guide for Patients and Families." The study is for women aged 18 and older who have been diagnosed with breast cancer (localized or advanced) and are waiting for ongoing counseling services. Researchers want to see if this one-time session is helpful and practical for participants. The study plans to enroll 26 people, but its current status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It aims to enroll 26 participants.
What's involved
You would participate in a one-time, 60-minute counseling session and receive a booklet. Acceptability will be measured for up to 3 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 3 months to assess the acceptability of the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07218250

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer

Recruiting
NAAges 18+InterventionalSupportive care
Memorial Sloan Kettering Cancer Center
~26 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:Single Counseling SessionAmerican Cancer Society booklet

At a glance

Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability (SSC-C participants)
Measured over up to 3 months
+1 more outcome measured

Conditions

Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

7 sites across 2 states
New York4
New Jersey3

Study leadership

  • Devika Jutagir, PhD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center

Who to contact

Devika Jutagir, PhD
[email protected]
646-888-8361
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient must have pathologically confirmed breast cancer (per EMR).
Patient with localized or advanced cancer (per EMR).
Patient is on a waitlist of at least 2 weeks or more for MSK Counseling Center intake and will not complete a New Visit with a clinical psychologist prior to intervention (these patients will be replaced) (per EMR, patient's care team, or self-report)
Has not had and is not scheduled to have an appointment with an MSK psychiatrist or MSK Counseling Center advanced practice provider (per EMR, patient's care team, or self-report)
Female (per EMR)
Age ≥ 18 (per EMR)
English fluency - Per self-report: How well do you speak English?
Agrees to be audio-recorded (per self-report) NOTE: Participants who report Very well are considered fluent.
Lives in New York, New Jersey, Connecticut, or Florida (per self-report).
Has no significant psychiatric disturbance sufficient to preclude completion of the assessment measures, interview, or informed consent (i.e., acute psychiatric symptoms which require urgent or extended individual treatment) (per EMR, patient's care team, or study team).
Has no presence of cognitive impairment disorder (i.e., delirium, dementia, or traumatic brain injury) sufficient to preclude meaningful informed consent and/or data collection (per EMR, patient's care team, study team, or per self-report of BOMC cognitive test).
Has no current active or passive suicidal ideation ((per EMR, patient's care team, study team, per item 9 of the PHQ-9, or the CSSRS).

What this trial measures

  • Acceptability (SSC-C participants)up to 3 months

    Participants will complete a satisfaction survey after completing the SSC-C intervention. A 5-item, investigator- initiated, face-valid satisfaction survey will assess the degree with which participant found SSC-C helpful in developing an action plan to address their concerns, their perceived utility of the action plan, the degree with which they believe they will use the action plan, their motivation to do so, and the extent to which they will recommend SSC-C to other patients.

  • Acceptability (PPSB participants)up to 3 months

    Participants will complete a satisfaction survey after receiving PPSB intervention materials. A 6-item, investigator- initiated, face-valid satisfaction survey will assess the degree with which participants found PPSB intervention helpful in developing an action plan to address their concerns, their perceived utility of the booklet, the degree with which they believe they will use the booklet, their motivation to do so, and the extent to which they will recommend the booklet materials to other patients.